EDGEMOND JAMES 4
4 · UNITED THERAPEUTICS Corp · Filed Jun 23, 2026
Research Summary
AI-generated summary of this filing
United Therapeutics (UTHR) CFO James Edgemond Exercises Options, Sells Shares
What Happened
- James Edgemond, CFO and Treasurer of United Therapeutics (UTHR), exercised 8,750 stock options on 2026-06-22 at $146.03 per share (exercise cost $1,277,763) and then sold the 8,750 shares the same day in multiple open-market trades.
- Sales were executed in several blocks with weighted-average prices and proceeds as reported:
- 164 shares @ weighted avg ~$534.06 = $87,586 (range $533.57–$534.53)
- 865 shares @ $534.98 = $462,762 (range $534.57–$535.56)
- 1,091 shares @ $536.05 = $584,827 (range $535.64–$536.47)
- 840 shares @ $537.18 = $451,234 (range $536.65–$537.59)
- 2,266 shares @ $538.23 = $1,219,638 (range $537.67–$538.66)
- 1,994 shares @ $539.13 = $1,075,025 (range $538.67–$539.66)
- 280 shares @ $539.83 = $151,151 (range $539.68–$539.92)
- 1,250 shares @ $541.25 = $676,563
- Total reported proceeds from the sales ≈ $4,708,786. Subtracting the exercise cost of ~$1,277,763 yields roughly $3,431,023 (pre-tax, not accounting for fees or withholdings).
Key Details
- Transaction date: June 22, 2026; Form 4 filed June 23, 2026 (timely filing).
- Option exercise: coded M (derivative exercise). Subsequent sales coded S (open-market sales).
- All sold shares equal the number exercised (8,750), indicating an immediate sale following exercise (commonly a cashless exercise plus sale).
- Notable footnotes: F1 — transactions were made pursuant to a Rule 10b5‑1 trading plan established Oct 31, 2025. F2–F8 — sales executed in multiple trades; reported prices are weighted averages and ranges are provided in the filing.
- Shares owned after the transaction: not provided in the material you supplied (not stated in this summary).
Context
- This is a routine insider activity pattern: exercising stock options and immediately selling the resulting shares under a pre‑existing 10b5‑1 plan. That structure is commonly used to avoid accusations of trading on nonpublic information and to provide automated execution.
- Transaction codes: M = option exercise/derivative conversion, S = sale. The filing also shows a technical "disposed @ $0.00" line tied to the derivative conversion; the economic effect is captured by the exercise cost and the sale proceeds above.
Insider Transaction Report
Form 4
EDGEMOND JAMES
CFO AND TREASURER
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-06-22$146.03/sh+8,750$1,277,763→ 27,626 total - Sale
Common Stock
[F1][F2]2026-06-22$534.06/sh−164$87,586→ 27,462 total - Sale
Common Stock
[F1][F3]2026-06-22$534.98/sh−865$462,762→ 26,597 total - Sale
Common Stock
[F1][F4]2026-06-22$536.05/sh−1,091$584,827→ 25,506 total - Sale
Common Stock
[F1][F5]2026-06-22$537.18/sh−840$451,234→ 24,666 total - Sale
Common Stock
[F1][F6]2026-06-22$538.23/sh−2,266$1,219,638→ 22,400 total - Sale
Common Stock
[F1][F7]2026-06-22$539.13/sh−1,994$1,075,025→ 20,406 total - Sale
Common Stock
[F1][F8]2026-06-22$539.83/sh−280$151,151→ 20,126 total - Sale
Common Stock
[F1]2026-06-22$541.25/sh−1,250$676,563→ 18,876 total - Exercise/Conversion
Stock Option
[F1]2026-06-22−8,750→ 0 totalExercise: $146.03From: 2020-03-15Exp: 2027-03-15→ Common Stock (8,750 underlying)
Footnotes (8)
- [F1]This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025.
- [F2]This transaction was executed in multiple trades at prices ranging from $533.57 to $534.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $534.57 to $535.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $535.64 to $536.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $536.65 to $537.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F6]This transaction was executed in multiple trades at prices ranging from $537.67 to $538.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F7]This transaction was executed in multiple trades at prices ranging from $538.67 to $539.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F8]This transaction was executed in multiple trades at prices ranging from $539.68 to $539.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Signature
/s/ John S. Hess, Jr. under Power of Attorney|2026-06-23